158 related articles for article (PubMed ID: 32868389)
1. Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal.
Rajabally YA; Peric S; Cobeljic M; Afzal S; Bozovic I; Palibrk A; Basta I
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1100-1104. PubMed ID: 32868389
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prevalence of CIDP and the association of diabetes mellitus.
Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
[TBL] [Abstract][Full Text] [Related]
3. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
4. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
[TBL] [Abstract][Full Text] [Related]
6. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
Sun QL; Sun AP; Fu Y; Fan DS
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
[TBL] [Abstract][Full Text] [Related]
7. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
8. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
9. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity between CIDP and diabetes mellitus: only a matter of chance?
Chiò A; Plano F; Calvo A; Leone M; Mutani R; Cocito D;
Eur J Neurol; 2009 Jun; 16(6):752-4. PubMed ID: 19475757
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.
Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A;
J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979
[TBL] [Abstract][Full Text] [Related]
12. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.
Rajabally YA; Peric S; Bozovic I; Loo LK; Kalac A; Palibrk A; Basta I
Muscle Nerve; 2021 Dec; 64(6):657-661. PubMed ID: 34263956
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
Lotan I; Hellman MA; Steiner I
Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
[TBL] [Abstract][Full Text] [Related]
14. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
15. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
[TBL] [Abstract][Full Text] [Related]
16. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.
Rajabally YA; Simpson BS; Beri S; Bankart J; Gosalakkal JA
Muscle Nerve; 2009 Apr; 39(4):432-8. PubMed ID: 19260065
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of chronic inflammatory neuropathies in southeast England.
Mahdi-Rogers M; Hughes RA
Eur J Neurol; 2014; 21(1):28-33. PubMed ID: 23679015
[TBL] [Abstract][Full Text] [Related]
20. Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates.
Rajabally YA; Cassereau J; Robbe A; Nicolas G
Eur J Neurol; 2015 Nov; 22(11):1469-73. PubMed ID: 26177936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
